Aug 2, 2022 4:10 pm EDT VolitionRx Limited Announces Closing of $6.9 Million Underwritten Public Offering of Common Stock
Jul 29, 2022 8:30 am EDT VolitionRx Limited Announces Pricing of $6 Million Underwritten Public Offering of Common Stock
Jul 28, 2022 4:10 pm EDT VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock
Jul 13, 2022 8:06 am EDT New NETs Data Presented at International Society on Thrombosis and Haemostasis (ISTH) Congress
May 11, 2022 4:10 pm EDT VolitionRx Limited Announces First Quarter 2022 Financial Results and Business Update
May 6, 2022 8:00 am EDT VolitionRx Limited Schedules First Quarter 2022 Earnings Conference Call and Business Update
Apr 25, 2022 8:00 am EDT Volition Launches its Nu.Q® Vet Cancer Test in Asia Through its Appointed Distributor SAGE Healthcare
